Akebia Therapeutics recalls
Akebia Therapeutics appears in 2 official U.S. recall notices indexed by RecallRadar, most recently on 2021-02-24.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 2 |
|---|---|
| Published | 2020-12-30 to 2021-02-24 |
| By agency | FDA Drug (2) |
| By classification | Class II (1), Class III (1) |
| By status | terminated (2) |
| Distribution named in notices | US |
Recalls
- Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC.…
FDA Drug · Class III · 2021-02-24 · Akebia Therapeutics
Reason: Failed Dissolution Specifications - Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC.,…
FDA Drug · Class II · 2020-12-30 · Akebia Therapeutics
Reason: CGMP Deviations